Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/04/2003WO2003057718A3 Genetic analysis systems and methods
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003055448A3 Antifungal compositions
12/04/2003WO2003054223A3 Tripartite molecular beacons
12/04/2003WO2003054209A3 A method of reducing non-specific amplification in pcr
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003054011A3 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
12/04/2003WO2003050310A3 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics
12/04/2003WO2003050264A3 Method for the analysis of differential gene expression
12/04/2003WO2003048329A3 Chromosomal saturation mutagenesis
12/04/2003WO2003047509A3 Enzyme activity profiles
12/04/2003WO2003046552A3 Screening method for compounds that modulate neuronal activity
12/04/2003WO2003044225A3 Profiling of the immune gene repertoire
12/04/2003WO2003038404A3 In vitro metabolic engineering on microscale devices
12/04/2003WO2003035894A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003027324A3 Expression profiling
12/04/2003WO2003025579A3 Use of heart fatty acid binding protein
12/04/2003WO2003021010A3 Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and dna sequencing
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003020900A3 Compositions and methods relating to breast specific genes and proteins
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003018755A3 Wild-type ras as a cancer therapeutic agent
12/04/2003WO2003016561A3 Method for the production of cna
12/04/2003WO2003016560A3 Methods for diagnosing and treating neoplasias using nf-at transcription factors
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2003012066A3 Magnesium precipitate hot start method for molecular manipulation of nucleic acids
12/04/2003WO2003012058A3 Media and methods for cultivation of microorganisms
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003008540A3 Abiotic stress responsive polynucleotides and polypeptides
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003006625A3 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
12/04/2003WO2003006504A3 Allelic variants of gpr50
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2003000904A3 Identification and characterization of plant genes
12/04/2003WO2003000897A3 Identification and characterization of phosphate transporter genes
12/04/2003WO2003000880A3 Homoaconitase as a target for fungicides
12/04/2003WO2003000416A3 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002099424A3 Acridone derivatives as labels for fluorescence detection of target materials
12/04/2003WO2002099068A3 LCES AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/04/2003WO2002097126A3 Method for detecting gram-positive bacteria having a high gc content
12/04/2003WO2002095066A3 Detecting microorganisms of the yersinia pestis/yersinia pseudotuberculosis species
12/04/2003WO2002095052A3 Pna probes, probe sets, methods and kits pertaining to the detection of candida
12/04/2003WO2002090992A3 Screening method
12/04/2003WO2002087499A3 Cells for detection of enteroviruses
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002074987A3 Quantitative diagnostic analysis of hypertonia
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002070555A3 Method of modulating the proliferation of medullary thyroid carcinoma cells
12/04/2003WO2002068684A8 Allele-specific primer extension assay
12/04/2003WO2002068678A3 Beta-lactamase substrates having phenolic ethers
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002062839A3 Markers of unstable atherosclerotic plaques
12/04/2003WO2002061123A3 Method of analysing dna methylation using fluorescence polarisation
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002053769A3 Dna chip for performing causal diagnosis of hypertension
12/04/2003WO2002039431A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002038810A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002036808A8 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003WO2002024947A3 Cancer associated protein kinases and their uses
12/04/2003WO2001096606A3 Identification of genes and compounds for treatment of cancer
12/04/2003WO2001050829A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
12/04/2003US20030226168 Plant preparations
12/04/2003US20030226164 Using recombinase to obtain site-specific recombination of DNA within dicotyledonous and monocotyledonous plant cells
12/04/2003US20030225530 Forensic investigations
12/04/2003US20030225529 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent for environmental testing thereby
12/04/2003US20030225528 Gene expression profiling in biopsied tumor tissues
12/04/2003US20030225322 Optical waveguide sensor, device, system and method for glucose measurement
12/04/2003US20030225261 Methods and compositions for mutation analysis of polynucleotides by liquid chromatography
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225247 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
12/04/2003US20030225117 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
12/04/2003US20030225046 Through modulation of the interaction of such hormone receptors with phosphatidylinositol-3 kinase
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225024 Method for deriving epitopes
12/04/2003US20030225022 Suppression of eIF5A1 expression to prevent retinal ganglion cell death in the glaucomatous eye
12/04/2003US20030225011 Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
12/04/2003US20030225008 Diagnosis of abnormal cellular proliferation by examining or monitoring cells for perturbations in H37 expression; treatment by inserting into H37 protein into a host cell
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224970 Methods for the identification of inhibitors of S-adenosylmethionine decarboxylase as antibiotics
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224519 Using chemical and insertional mutagenesis to determine genic function
12/04/2003US20030224517 Comprises oligonucleotides which inhibit secretase activity on amyloid precursor proteins (APP) for treating alzheimer's and neurodegenerative diseases
12/04/2003US20030224501 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
12/04/2003US20030224500 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224474 Apparatus for detection of rohypnol, gamma hydroxyl butyrate, and ketamine; drug screening; colorimetric analysis
12/04/2003US20030224473 Methods for screening for histone deacetylase activity and for identifying histone deacetylase inhibitors
12/04/2003US20030224472 Useful for the identification of antibiotics, preferably antifungals
12/04/2003US20030224471 Apparatus for measuring serum cholesterol associated with high-density lipoproteins (HDL) in blood fluid sample; diagnosing cardiovascular disorders and coronary artery disease
12/04/2003US20030224467 AIB1 as a prognostic marker and predictor of resistance to endocrine therapy
12/04/2003US20030224466 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
1 ... 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 ... 3003